LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 76

Search options

  1. Article ; Online: Which are the best murine models to study Eosinophilic Chronic Rhinosinusitis? A contemporary review.

    Leite-Santos, Francisco / Tamashiro, Edwin / de Andrade Batista Murashima, Adriana / Anselmo-Lima, Wilma T / Valera, Fabiana C P

    Brazilian journal of otorhinolaryngology

    2023  Volume 89, Issue 6, Page(s) 101328

    Abstract: Objective: Mechanisms that lead to Eosinophilic Chronic Rhinosinusitis (ECRS) are not fully established in the literature. It is desirable to assess ECRS in a model that embraces most of the related events. This article reviewed the murine models for ... ...

    Abstract Objective: Mechanisms that lead to Eosinophilic Chronic Rhinosinusitis (ECRS) are not fully established in the literature. It is desirable to assess ECRS in a model that embraces most of the related events. This article reviewed the murine models for ECRS and compared them regarding eosinophilic polypoid formation.
    Methods: The authors reviewed the articles that included the terms "chronic rhinosinusitis" OR "chronic sinusitis" AND "animal model". We analyzed articles in English that evaluated both the number of polyps and the number of eosinophils in the sinus mucosa of mouse models.
    Results: We identified a total of 15 articles describing different models of ECRS that used BALB/c or C57BL/6 mice, and different triggers/stimulants such as Staphylococcus aureus Enterotoxin B (SEB) + Ovalbumin (OVA); House Dust Mite (HDM) ± Ovalbumin (OVA); and Aspergillus oryzae Protease (AP) + Ovalbumin (OVA). OVA associated with SEB was the commonest protocol to induce ECRS in both BALB/c and C57BL/6 mice, and it produced a robust response of eosinophilic nasal polyps in both. AP + OVA protocol also led to a good ECRS response. The other models were not considered adequate to produce eosinophilic polyps in mice.
    Conclusion: In conclusion, OVA associated with SEB seems to produce the most robust eosinophilic sinonasal inflammation.
    Language English
    Publishing date 2023-09-15
    Publishing country Brazil
    Document type Journal Article ; Review
    ZDB-ID 2428110-4
    ISSN 1808-8686 ; 1808-8694
    ISSN (online) 1808-8686
    ISSN 1808-8694
    DOI 10.1016/j.bjorl.2023.101328
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Revisiting the orbital complications of acute rhinosinusitis.

    Anselmo-Lima, Wilma T / Soares, Mateus R / Fonseca, Jefferson P / Garcia, Denny M / Velasco E Cruz, Antonio A / Tamashiro, Edwin / Valera, Fabiana C P

    Brazilian journal of otorhinolaryngology

    2023  Volume 89, Issue 5, Page(s) 101316

    MeSH term(s) Humans ; Retrospective Studies ; Abscess/diagnostic imaging ; Abscess/etiology ; Rhinitis/complications ; Rhinitis/diagnostic imaging ; Rhinitis/surgery ; Orbital Cellulitis/diagnostic imaging ; Orbital Cellulitis/etiology ; Sinusitis/complications ; Sinusitis/diagnostic imaging ; Sinusitis/surgery ; Acute Disease ; Orbital Diseases/etiology ; Orbital Diseases/complications
    Language English
    Publishing date 2023-08-30
    Publishing country Brazil
    Document type Journal Article
    ZDB-ID 2428110-4
    ISSN 1808-8686 ; 1808-8694
    ISSN (online) 1808-8686
    ISSN 1808-8694
    DOI 10.1016/j.bjorl.2023.101316
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update.

    Anselmo-Lima, Wilma T / Romano, Fabrizio R / Tamashiro, Edwin / Roithmann, Renato / Dinarte, Vanessa R P / Piltcher, Otavio B / Miyake, Marcel M / Fornazieri, Marco A / Nakanishi, Marcio / Bezerra, Thiago F P / Dolci, Ricardo L L / Mello, João F / Lessa, Marcus M / Voegels, Richard L / Kosugi, Eduardo M / Sakano, Eulalia / Valera, Fabiana C P

    Brazilian journal of otorhinolaryngology

    2024  Volume 90, Issue 3, Page(s) 101394

    Abstract: Introduction: Biologics targeting type 2 inflammation have revolutionized the way we treat patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Particularly in severe and difficult-to-control cases, these drugs have provided a new reality ... ...

    Abstract Introduction: Biologics targeting type 2 inflammation have revolutionized the way we treat patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Particularly in severe and difficult-to-control cases, these drugs have provided a new reality for these patients, allowing for the effective and safe treatment of extensive diseases that were not completely managed with the typical strategy of surgery and topical medications.
    Objectives: The experience achieved with the approval of these medications by ANVISA for use in CRSwNP and the knowledge obtained regarding outcomes, adverse effects, and the ideal patient profile prompted the update of the previously published guideline, with a detailed review of the most recent scientific literature, the personal experiences of experts, and the adaptation to the reality of the Brazilian healthcare system, both public and private.
    Results: We proposed a new eligibility criterion for biologics in patients with CRSwNP based on four pillars of indication: the impact of the disease on the patient's life, whether in the presence of specific symptoms or in overall quality of life; the extent of sinonasal disease; the presence of type 2 comorbidities, considering other associated diseases that may also benefit from anti-T2 biologics, and the presence of biomarkers to define type 2 inflammation, especially those associated with worse disease prognoses.
    Conclusions: This innovative and pioneering method has two major advantages. First, it ensures a comprehensive evaluation of patients; second, it is flexible, as advancements in our understanding of the disease and changes in cost-effectiveness can be addressed by simply adjusting the required score for indication, without the need to modify the entire evaluation scheme.
    Language English
    Publishing date 2024-01-30
    Publishing country Brazil
    Document type Journal Article ; Review
    ZDB-ID 2428110-4
    ISSN 1808-8686 ; 1808-8694
    ISSN (online) 1808-8686
    ISSN 1808-8694
    DOI 10.1016/j.bjorl.2024.101394
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Biofilm and Planktonic Antibiotic Resistance in Patients With Acute Exacerbation of Chronic Rhinosinusitis.

    Sabino, Henrique Augusto Cantareira / Valera, Fabiana Cardoso Pereira / Santos, Denise Vieira / Fantucci, Marina Zilio / Titoneli, Carolina Carneiro / Martinez, Roberto / Anselmo-Lima, Wilma T / Tamashiro, Edwin

    Frontiers in cellular and infection microbiology

    2022  Volume 11, Page(s) 813076

    Abstract: Introduction: The recalcitrant nature of patients with acute exacerbation of chronic rhinosinusitis (AECRS) potentially involves persisting colonization of the sinonasal mucosa by bacterial biofilms. Biofilms are known to be highly resistant to ... ...

    Abstract Introduction: The recalcitrant nature of patients with acute exacerbation of chronic rhinosinusitis (AECRS) potentially involves persisting colonization of the sinonasal mucosa by bacterial biofilms. Biofilms are known to be highly resistant to antibiotics, which may trigger or maintain chronic inflammation in the sinonasal mucosa. However, little is known about the relationship between the minimum inhibitory concentration (MIC) and antibiofilm concentrations of bacteria obtained from AECRS patients.
    Material and methods: Thirty bacterial strains from 25 patients with AECRS were identified and underwent MIC determination (VITEK
    Results: The main bacteria retrieved was
    Conclusions: Biofilm-forming bacteria from AECRS patients are prevalent, and biofilm forms are highly resistant to antibiotics compared to their planktonic counterparts. Antibiotic resistance observed in planktonic forms is a good indicator of biofilm resistance, although near 20% of susceptible planktonic bacteria can produce antibiotic tolerant biofilms.
    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Biofilms ; Drug Resistance, Microbial ; Gram-Negative Bacteria ; Gram-Positive Bacteria ; Humans ; Microbial Sensitivity Tests ; Plankton ; Staphylococcus aureus
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-01-17
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2021.813076
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Chronic rhinosinusitis with nasal polyps does not harbor KRAS, BRAF, and EGFR mutations.

    da Silva Vieira, Tamara / Guimarães, Letícia Martins / Diniz, Marina Gonçalves / Gomes-Fernandes, Bianca / Anselmo-Lima, Wilma Terezinha / Tamashiro, Edwin / Bastos-Rodrigues, Luciana / De Marco, Luiz / Gomez, Ricardo Santiago / Valera, Fabiana Cardoso Pereira / Gomes, Carolina Cavalieri

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

    2022  Volume 52, Issue 5, Page(s) 426–430

    Abstract: Background: Chronic rhinosinusitis is a chronic inflammation of the nasal mucosa and nasal polyps are present in ~25%-30% of cases (chronic rhinosinusitis with nasal polyps [CRSwNP]). CRSwNP is associated with significant morbidity and decreased quality ...

    Abstract Background: Chronic rhinosinusitis is a chronic inflammation of the nasal mucosa and nasal polyps are present in ~25%-30% of cases (chronic rhinosinusitis with nasal polyps [CRSwNP]). CRSwNP is associated with significant morbidity and decreased quality of life, making it clinically important. Inflammation leads to DNA damage and DNA mutations occur in some inflammatory diseases. Notably, mutations in KRAS, BRAF, and EGFR have been reported in different human benign and malignant neoplastic lesions. In addition, KRAS mutations have also been reported in non-neoplastic tissues under chronic inflammatory conditions. Importantly, KRAS mutations have been reported in oncocytic sinonasal papillomas and sinonasal squamous cell carcinoma associated with oncocytic sinonasal papilloma and EGFR mutations have been reported in sinonasal adenocarcinoma, inverted sinonasal papilloma, and sinonasal squamous cell carcinoma associated with inverted sinonasal papilloma. The molecular pathogenesis of nasal polyps remains unclear. Therefore, the present study aimed to investigate the presence of KRAS, BRAF, and EGFR pathogenic mutations in CRSwNP.
    Methods: Fourteen chronic rhinosinusitis-associated nasal polyp samples were direct sequenced, targeting KRAS exons 2, 3, and 4 (encompassing important hotspot mutations, including codons 12, 13, 61 and 146), BRAF exons 11 and 15, and EGFR exons 19 and 20.
    Results: No pathogenic mutations were detected in the sequenced regions of KRAS, BRAF, and EGFR genes.
    Conclusion: This finding suggests that mutations in these genes are not a frequent event in CRSwNP, and, if they occur, they might represent marginal events at best.
    MeSH term(s) Humans ; Nasal Polyps/complications ; Nasal Polyps/genetics ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins p21(ras)/genetics ; Quality of Life ; Mutation ; Sinusitis/complications ; Sinusitis/genetics ; Head and Neck Neoplasms ; Squamous Cell Carcinoma of Head and Neck ; Papilloma/genetics ; Inflammation ; ErbB Receptors/genetics ; Chronic Disease
    Chemical Substances Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2) ; ErbB Receptors (EC 2.7.10.1) ; KRAS protein, human ; BRAF protein, human (EC 2.7.11.1) ; EGFR protein, human (EC 2.7.10.1)
    Language English
    Publishing date 2022-10-03
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1021270-x
    ISSN 1600-0714 ; 0904-2512
    ISSN (online) 1600-0714
    ISSN 0904-2512
    DOI 10.1111/jop.13356
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Clearance of Pneumococcal Colonization in Infants Is Delayed through Altered Macrophage Trafficking.

    Siegel, Steven J / Tamashiro, Edwin / Weiser, Jeffrey N

    PLoS pathogens

    2015  Volume 11, Issue 6, Page(s) e1005004

    Abstract: Infections are a common cause of infant mortality worldwide, especially due to Streptococcus pneumoniae. Colonization is the prerequisite to invasive pneumococcal disease, and is particularly frequent and prolonged in children, though the mechanisms ... ...

    Abstract Infections are a common cause of infant mortality worldwide, especially due to Streptococcus pneumoniae. Colonization is the prerequisite to invasive pneumococcal disease, and is particularly frequent and prolonged in children, though the mechanisms underlying this susceptibility are unknown. We find that infant mice exhibit prolonged pneumococcal carriage, and are delayed in recruiting macrophages, the effector cells of clearance, into the nasopharyngeal lumen. This lack of macrophage recruitment is paralleled by a failure to upregulate chemokine (C-C) motif ligand 2 (Ccl2 or Mcp-1), a macrophage chemoattractant that is required in adult mice to promote clearance. Baseline expression of Ccl2 and the related chemokine Ccl7 is higher in the infant compared to the adult upper respiratory tract, and this effect requires the infant microbiota. These results demonstrate that signals governing macrophage recruitment are altered at baseline in infant mice, which prevents the development of appropriate innate cell infiltration in response to pneumococcal colonization, delaying clearance of pneumococcal carriage.
    MeSH term(s) Animals ; Animals, Newborn ; Cell Movement/physiology ; Chemokine CCL2/immunology ; Macrophages/immunology ; Mice, Inbred C57BL ; Nasopharynx/immunology ; Pneumococcal Infections/immunology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines/immunology ; Streptococcus pneumoniae/growth & development ; Streptococcus pneumoniae/immunology
    Chemical Substances Ccl2 protein, mouse ; Chemokine CCL2 ; Pneumococcal Vaccines
    Language English
    Publishing date 2015-06-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2205412-1
    ISSN 1553-7374 ; 1553-7366
    ISSN (online) 1553-7374
    ISSN 1553-7366
    DOI 10.1371/journal.ppat.1005004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Biodegradable Electrospun Nanofibers: A New Approach For Rhinosinusitis Treatment.

    Rivelli, Graziella Gomes / Perez, André Coura / Silva, Pedro Henrique Reis / Gomes, Elionai Cassiana de Lima / Moreira, Carolina Paula de Souza / Tamashiro, Edwin / Valera, Fabiana Cardoso Pereira / Anselmo-Lima, Wilma Terezinha / Pianetti, Gérson Antônio / Silva-Cunha, Armando

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

    2021  Volume 163, Page(s) 105852

    Abstract: Biodegradable polymeric nanofibers containing mometasone furoate can be a new approach to drug delivery to treat chronic rhinosinusitis, providing controlled steroid delivery to the sinonasal mucosa. This study aimed to develop biodegradable polymeric ... ...

    Abstract Biodegradable polymeric nanofibers containing mometasone furoate can be a new approach to drug delivery to treat chronic rhinosinusitis, providing controlled steroid delivery to the sinonasal mucosa. This study aimed to develop biodegradable polymeric nanofibers and explore the safety of these fibers in an in vivo rabbit model. The nanofibers' development has been optimized using the Response Surface Methodology (RSM) obtained with Design of Experiments (DoE) with the best conditions related to the polymer concentration and proportion of solvents used in the electrospinning process. The nanofibers were prepared, operating as a determinant factor, the nanofiber formation and its diameter evaluated by Scanning Electron Microscopy (SEM). The ideal system obtained was assessed by SEM, thermogravimetric analysis (TGA), X-ray diffraction (XRD), differential scanning calorimetry (DSC), assay, and drug delivery by UHLPC validated method. The results showed that the drug is dispersed in the polymeric matrix, is stable, and showed sustained release kinetics in a bio-relevant nasal environment (Higuchi model kinetics). In vivo tests, the level of inflammation at the animals' mucosa which received the nanofiber with the mometasone furoate was lower than those that received the nanofibers without the drug (α = 0.05). Histopathology analysis showed that the polymeric nanofibers containing mometasone are safe when topically applied on the sinonasal mucosa, opening a new horizon in chronic rhinosinusitis treatment.
    MeSH term(s) Animals ; Calorimetry, Differential Scanning ; Microscopy, Electron, Scanning ; Nanofibers ; Polymers ; Rabbits ; X-Ray Diffraction
    Chemical Substances Polymers
    Language English
    Publishing date 2021-04-20
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1154366-8
    ISSN 1879-0720 ; 0928-0987
    ISSN (online) 1879-0720
    ISSN 0928-0987
    DOI 10.1016/j.ejps.2021.105852
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Clearance of Pneumococcal Colonization in Infants Is Delayed through Altered Macrophage Trafficking.

    Steven J Siegel / Edwin Tamashiro / Jeffrey N Weiser

    PLoS Pathogens, Vol 11, Iss 6, p e

    2015  Volume 1005004

    Abstract: Infections are a common cause of infant mortality worldwide, especially due to Streptococcus pneumoniae. Colonization is the prerequisite to invasive pneumococcal disease, and is particularly frequent and prolonged in children, though the mechanisms ... ...

    Abstract Infections are a common cause of infant mortality worldwide, especially due to Streptococcus pneumoniae. Colonization is the prerequisite to invasive pneumococcal disease, and is particularly frequent and prolonged in children, though the mechanisms underlying this susceptibility are unknown. We find that infant mice exhibit prolonged pneumococcal carriage, and are delayed in recruiting macrophages, the effector cells of clearance, into the nasopharyngeal lumen. This lack of macrophage recruitment is paralleled by a failure to upregulate chemokine (C-C) motif ligand 2 (Ccl2 or Mcp-1), a macrophage chemoattractant that is required in adult mice to promote clearance. Baseline expression of Ccl2 and the related chemokine Ccl7 is higher in the infant compared to the adult upper respiratory tract, and this effect requires the infant microbiota. These results demonstrate that signals governing macrophage recruitment are altered at baseline in infant mice, which prevents the development of appropriate innate cell infiltration in response to pneumococcal colonization, delaying clearance of pneumococcal carriage.
    Keywords Immunologic diseases. Allergy ; RC581-607 ; Biology (General) ; QH301-705.5
    Language English
    Publishing date 2015-06-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study.

    Silva, Marcela de Oliveira / de Sousa, Graziella Ribeiro / Simões, Sarah Capelupe / Nicolucci, Patrícia / Tamashiro, Edwin / Saggioro, Fabiano / de Oliveira, Ricardo Santos / Brassesco, María Sol

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

    2021  Volume 37, Issue 7, Page(s) 2163–2175

    Abstract: Purpose: Inhalation of perillyl alcohol (POH) recently emerged as an investigational promising antiglioma strategy. However, little attention has been paid to its therapeutic potential for other brain tumors, especially in the pediatric setting.: ... ...

    Abstract Purpose: Inhalation of perillyl alcohol (POH) recently emerged as an investigational promising antiglioma strategy. However, little attention has been paid to its therapeutic potential for other brain tumors, especially in the pediatric setting.
    Methods: The effects of POH were explored in medulloblastoma cell models belonging to the SHH variant with activation of RAS (ONS-76) or with TP53 mutations (DAOY and UW402), by means of proliferation and invasion assays. Interactions with methotrexate, thiotepa, or ionizing radiation were also assessed. Mice bearing subcutaneous tumors were treated with intraperitoneal injections. Alternatively, animals with intracranial tumors were exposed to intranasal POH alone or combined with radiation. Tumor growth was measured by bioluminescence. Analyses of cytotoxicity to the nasal cavity were also performed, and the presence of POH in the brain, lungs, and plasma was surveyed through chromatography/mass spectrometry.
    Results: POH decreased cell proliferation and colony formation, with conspicuous death, though the invasive capacity was only affected in the NRAS-mutated cell line. Median-drug effect analysis displayed synergistic combinations with methotrexate. Otherwise, POH showed to be a reasonable radiosensitizer. In vivo, intraperitoneal injection significantly decreased tumor volume. However, its inhalation did not affect orthotopic tumors, neither alone or followed by cranial irradiation. Nasal cavity epithelium showed unimportant alterations, though, no traces of POH or its metabolites were detected in tissue samples.
    Conclusion: POH presents robust in vitro antimedulloblastoma effects and sensitizes cell lines to other conventional therapeutics, reducing tumor volume when administered intraperitoneally. Nevertheless, further improvement of delivery devices and/or drug formulations are needed to better characterize its effectiveness through inhalation.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Cerebellar Neoplasms/drug therapy ; Child ; Hedgehog Proteins ; Humans ; Medulloblastoma/drug therapy ; Medulloblastoma/genetics ; Mice ; Monoterpenes ; Tumor Suppressor Protein p53 ; ras Proteins
    Chemical Substances Antineoplastic Agents ; Hedgehog Proteins ; Monoterpenes ; SHH protein, human ; TP53 protein, human ; Tumor Suppressor Protein p53 ; perillyl alcohol (319R5C7293) ; ras Proteins (EC 3.6.5.2)
    Language English
    Publishing date 2021-04-22
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 605988-0
    ISSN 1433-0350 ; 0302-2803 ; 0256-7040
    ISSN (online) 1433-0350
    ISSN 0302-2803 ; 0256-7040
    DOI 10.1007/s00381-021-05115-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Does ibuprofen, prednisolone, or amoxicillin reduce post-tonsillectomy pain in children? A prospective randomized controlled trial.

    de Azevedo, Carolina B / Valera, Fabiana C P / Carenzi, Lucas R / Küpper, Daniel S / Caetano, João Vitor B / Queiroz, Danielle L C / Anselmo-Lima, Wilma T / Tamashiro, Edwin

    International journal of pediatric otorhinolaryngology

    2021  Volume 148, Page(s) 110824

    Abstract: Objective: To evaluate whether the use of anti-inflammatory or antibiotic in the postoperative period modifies pain in children undergoing tonsillectomy.: Methods: 225 children who underwent cold knife tonsillectomy ± adenoidectomy were randomized ... ...

    Abstract Objective: To evaluate whether the use of anti-inflammatory or antibiotic in the postoperative period modifies pain in children undergoing tonsillectomy.
    Methods: 225 children who underwent cold knife tonsillectomy ± adenoidectomy were randomized into five groups, receiving #1 metamizole/acetaminophen, #2 amoxicillin, #3 ibuprofen, #4 prednisolone, or #5 amoxicillin plus prednisolone. All groups received oral analgesics (metamizole/acetaminophen) to use as needed. Pain was monitored during the 7 days following surgery using the Parents' Postoperative Pain Measurement (PPPM) and the Faces Pain Scale - Revised (FPS-R). Pain was also indirectly evaluated by the dose of analgesics administered on each day and by the time needed to return to a solid diet.
    Results: After losses (24%), 170 individuals were submitted for analysis. Multiple comparisons demonstrated that the evolution of pain between the different groups, as matched day-per-day, was not significantly different by either PPPM or FPS-R (p > 0.05). The instances of analgesic intake were also similar in all the groups (p > 0.05), as was the return to solid food ingestion (p = 0.41). All groups presented a similar standard of clinical improvement at intervals of 2 days (p < 0.01). Independent of postoperative pain management, patients developed significant pain up to the day 4 following surgery.
    Conclusion: The addition of amoxicillin, ibuprofen, prednisolone, or amoxicillin and prednisolone does not modify postoperative pain in children undergoing cold-knife tonsillectomy. Special pain control should be performed on the first 4 days following tonsillectomy in children.
    MeSH term(s) Amoxicillin ; Analgesics, Non-Narcotic/therapeutic use ; Child ; Humans ; Ibuprofen/therapeutic use ; Pain, Postoperative/diagnosis ; Pain, Postoperative/drug therapy ; Pain, Postoperative/prevention & control ; Prednisolone ; Prospective Studies ; Tonsillectomy/adverse effects
    Chemical Substances Analgesics, Non-Narcotic ; Amoxicillin (804826J2HU) ; Prednisolone (9PHQ9Y1OLM) ; Ibuprofen (WK2XYI10QM)
    Language English
    Publishing date 2021-06-30
    Publishing country Ireland
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 754501-0
    ISSN 1872-8464 ; 0165-5876
    ISSN (online) 1872-8464
    ISSN 0165-5876
    DOI 10.1016/j.ijporl.2021.110824
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top